• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV410T
Device Problem Infusion or Flow Problem (2964)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 09/27/2019
Event Type  Injury  
Manufacturer Narrative
Height: 130 cm.When additional information becomes available, a follow up report will be submitted.
 
Event Description
It was reported that the valve over drained.The reporter indicated that a 6 year post-operative valve is over draining and required explantation.Additional details of the event and patient information is not available.
 
Manufacturer Narrative
Investigation: visual inspection no significant deformations or damage of the valve was detected during the visual inspection.The progav valve housing was subsequently measured and indicated a slightly presence of a deformation.The housing deformation measured at -0.026 mm, outside the tolerance of 0 ± 0.02 mm.Permeability test a permeability test has shown that the progav valve is permeable.Adjustment test the progav valve was tested and is adjustable to all specified pressures.Braking force and brake function test the brake functionality test has shown that the brake function operates as expected.However, the breaking force required was not within the specified tolerances.Computer controlled test to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.At the first measurement, the valve does not operate within the allowable tolerance.At the second measurement, the valve operates with the acceptable tolerance.This can be caused by rinsing during the test procedure.Results first, we performed a visual inspection of the progav valve.No significant deformations or damage of the valve was detected during the visual inspection.Next, we tested the permeability, adjustability and opening pressure of the valve, as well as the brake functionality and brake force.The opening pressure and the braking force of the progav valve was out of tolerance, but all other specifications were met.The opening pressure of the progav was significantly lower than expected, indicating a tendency towards over-drainage.Finally, we have dismantled the valve.Inside the valve, we have found build-up of substances (likely protein).Based on our investigation, we confirm that the progav valve was operating in an over-drainage state at the time of our investigation.This is likely due to the deposits observed inside the valves.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.The cause of the deformation of the progav valve and the resultant of the lower braking force could not be determined through our investigation.Significant outside pressure, for example by too much force from the progav adjustment tool or by a fall or impact to the head of the patient, can compromise the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9219198
MDR Text Key163340546
Report Number3004721439-2019-00259
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2017
Device Model NumberFV410T
Device Catalogue NumberFV410T
Device Lot Number4505171947
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/30/2019
Date Manufacturer Received10/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age6 YR
Patient Weight25
-
-